vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and MGIC INVESTMENT CORP (MTG). Click either name above to swap in a different company.
MGIC INVESTMENT CORP is the larger business by last-quarter revenue ($297.1M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). MGIC INVESTMENT CORP runs the higher net margin — 55.6% vs 0.7%, a 54.9% gap on every dollar of revenue. On growth, MGIC INVESTMENT CORP posted the faster year-over-year revenue change (-3.0% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
MGIC Investment Corporation NYSE: MTG ("MGIC") is a provider of private mortgage insurance in the United States. The company is headquartered in Milwaukee, Wisconsin.
HCM vs MTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $297.1M |
| Net Profit | $2.0M | $165.3M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | 55.6% |
| Revenue YoY | -16.5% | -3.0% |
| Net Profit YoY | -83.6% | -10.9% |
| EPS (diluted) | $0.00 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $297.1M | ||
| Q4 25 | $270.8M | $298.7M | ||
| Q3 25 | — | $304.5M | ||
| Q2 25 | $277.7M | $304.2M | ||
| Q1 25 | $324.5M | $306.2M | ||
| Q4 24 | — | $301.4M | ||
| Q3 24 | — | $306.6M | ||
| Q2 24 | $305.7M | $305.3M |
| Q1 26 | — | $165.3M | ||
| Q4 25 | $2.0M | $169.3M | ||
| Q3 25 | — | $191.1M | ||
| Q2 25 | $455.0M | $192.5M | ||
| Q1 25 | $11.9M | $185.5M | ||
| Q4 24 | — | $184.7M | ||
| Q3 24 | — | $200.0M | ||
| Q2 24 | $25.8M | $204.2M |
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | -13.2% | 71.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | -1.3% | 80.9% | ||
| Q1 25 | -5.0% | 76.6% | ||
| Q4 24 | — | 77.9% | ||
| Q3 24 | — | 82.9% | ||
| Q2 24 | -9.0% | 85.1% |
| Q1 26 | — | 55.6% | ||
| Q4 25 | 0.7% | 56.7% | ||
| Q3 25 | — | 62.8% | ||
| Q2 25 | 163.8% | 63.3% | ||
| Q1 25 | 3.7% | 60.6% | ||
| Q4 24 | — | 61.3% | ||
| Q3 24 | — | 65.2% | ||
| Q2 24 | 8.4% | 66.9% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.00 | $0.75 | ||
| Q3 25 | — | $0.83 | ||
| Q2 25 | $0.52 | $0.81 | ||
| Q1 25 | $0.01 | $0.75 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | $0.03 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $235.1M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $5.0B |
| Total Assets | $1.8B | $6.4B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $235.1M | ||
| Q4 25 | $1.4B | $369.0M | ||
| Q3 25 | — | $266.9M | ||
| Q2 25 | $1.4B | $294.9M | ||
| Q1 25 | $836.1M | $207.0M | ||
| Q4 24 | — | $229.5M | ||
| Q3 24 | — | $288.6M | ||
| Q2 24 | $802.5M | $281.8M |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
| Q1 26 | — | $5.0B | ||
| Q4 25 | $1.2B | $5.1B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | $1.2B | $5.2B | ||
| Q1 25 | $759.9M | $5.1B | ||
| Q4 24 | — | $5.2B | ||
| Q3 24 | — | $5.3B | ||
| Q2 24 | $740.1M | $5.1B |
| Q1 26 | — | $6.4B | ||
| Q4 25 | $1.8B | $6.6B | ||
| Q3 25 | — | $6.6B | ||
| Q2 25 | $1.8B | $6.5B | ||
| Q1 25 | $1.3B | $6.5B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.7B | ||
| Q2 24 | $1.3B | $6.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $230.8M | ||
| Q3 25 | — | $215.4M | ||
| Q2 25 | $-72.9M | $183.0M | ||
| Q1 25 | $40.3M | $223.7M | ||
| Q4 24 | — | $182.4M | ||
| Q3 24 | — | $182.9M | ||
| Q2 24 | $-39.8M | $169.2M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $230.2M | ||
| Q3 25 | — | $215.1M | ||
| Q2 25 | $-82.2M | $183.0M | ||
| Q1 25 | $32.5M | $223.5M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $182.5M | ||
| Q2 24 | $-49.9M | $169.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 77.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | -29.6% | 60.1% | ||
| Q1 25 | 10.0% | 73.0% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | -16.3% | 55.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 0.2% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 3.3% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | 1.36× | ||
| Q3 25 | — | 1.13× | ||
| Q2 25 | -0.16× | 0.95× | ||
| Q1 25 | 3.38× | 1.21× | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | -1.54× | 0.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
